Ozempic CEO agrees to discuss lower prices for blockbuster weight loss drugs
Sort by
264 items
-
The Wall Street Journal - Tech
Chip Giants TSMC and Samsung Discuss Building Middle Eastern Megafactories
Potential projects in the United Arab Emirates could be worth more than $100 billion, though major hurdles remain.2 days ago -
Yahoo Sports - Sports
Rockets agree to buyout, waive 2022 first-round pick A.J. Griffin who may step away from sport
Griffin is expected to be away from the NBA for at least this season.2 days ago -
CNBC - Business
How to position your investment portfolio for lower rates, according to experts
Money managers suggest it could be time to load up on rate-sensitive assets as the Federal Reserve eases monetary policy.2 days ago -
Financial Times - World
The path to global carbon pricing
To tackle climate change, the polluter pays principle needs to spread further and wider2 days ago -
CNBC - Business
Harris agrees to CNN debate on Oct. 23, Trump says 'it's too late'
Kamala Harris raised millions after going up against Donald Trump in a presidential debate earlier this month. Now Harris is ready for a second round.3 days ago - Donald Trump -
CBS News - Top stories
As weight loss drugs explode in popularity, are online marketplaces safe?
Weight loss drugs are exploding in popularity, with 1 in 8 Americans saying they have tried medications like Ozempic and Wegovy to tackle everything from diabetes to weight loss, among other ...3 days ago -
CNBC - Business
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.3 days ago -
CBS News - Top stories
Inside the thriving market for alternatives to brand-name weight loss drugs
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.3 days ago -
The New York Times - Health
Drug Overdose Deaths Are Dropping. The Reasons Are Not Perfectly Clear.
The decrease across the country is a major breakthrough in efforts to reverse the effects of fentanyl. Researchers and health officials say there is no easy explanation for the trend.3 days ago -
The New York Times - Health
Drug Overdose Deaths Are Dropping. The Reasons Are Not Perfectly Clear.
The decrease across the country is a major breakthrough in efforts to reverse the effects of fentanyl. Researchers and health officials say there is no easy explanation for the trend.3 days ago -
The New York Times - Top stories
Nelson DeMille, Blockbuster Author Who Thrilled Millions, Dies at 81
In best seller after best seller, world-weary investigators tackled military malfeasance and Russian spies, cracking jokes and beers to the delight of legions of devoted fans.3 days ago -
NBC News - Top stories
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.4 days ago -
ESPN - Sports
Sources: Embiid agrees to 3-year, $192.9M deal
Saying he hopes to be a Sixer "for the rest of my career," Joel Embiid reached a three-year contract extension with the team that sources told ESPN's Ramona Shelburne is worth $192.9 million.4 days ago - NBA -
ABC News - Health
An appeals court has revived a challenge to President Biden's Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription drugs has been revived by a federal appeals court4 days ago - Joe Biden -
NBC News - Top stories
Olivia Rodrigo made her ticket prices lower for her show in the Philippines, and fans are thrilled
Olivia Rodrigo is taking her tour to the Philippines for the first time, and her fans in Manila couldn’t be happier with the ticket prices.4 days ago -
The Hill - Politics
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially” ...4 days ago -
MarketWatch - Business
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.4 days ago -
The New York Times - Health
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.4 days ago -
The New York Times - Business
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.4 days ago -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high4 days ago -
Inc. - Business
Amazon and Starbucks CEOs Present Contrast in RTO Mandates
While Amazon's Andy Jassy got criticized for his order to resume a five-day week in the office, incoming Starbucks CEO Brian Niccol encouraged full-week presence--but will let employees decide for ...4 days ago - Amazon -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.4 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.4 days ago -
CBS News - Top stories
Kamala Harris discusses her gun ownership on livestream with Oprah
Thursday night in her livestream with Oprah, Kamala Harris discussed her gun ownership, saying, "If somebody breaks in my house they're getting shot." CBS News campaign reporter Shawna Mizelle has ...4 days ago - Kamala Harris -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.4 days ago -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.4 days ago -
The Hill - Politics
Harris and Oprah hold star-studded event to discuss hot-button issues
Vice President Harris and media mogul Oprah Winfrey sat down for an event in Michigan to discuss issues ranging from immigration to the economy, reproductive rights and gun violence prevention. The ...4 days ago -
The Wall Street Journal - Business
FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue
FedEx’s results were dragged down by weaker-than-expected demand, particularly in the U.S. domestic package market.5 days ago -
The Wall Street Journal - Business
FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue
FedEx’s results were dragged down by weaker-than-expected demand, particularly in the U.S. domestic package market.5 days ago -
The New York Times - Health
Research Leading to Ozempic Honored by 2024 Lasker Awards
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to stop H.I.V. and for immune system discoveries.5 days ago